Status:
COMPLETED
Cocoa Ileostomy Study
Lead Sponsor:
University of Ulster
Collaborating Sponsors:
University of California, Davis
Conditions:
Ileostomy - Stoma
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
There is substantial interest in the potential role of chocolate and its primary bioactive component; flavan-3-ol, (-)-epicatechin, in both the prevention and management of cardiovascular disease (CVD...
Eligibility Criteria
Inclusion
- Undergone an ileostomy and be more than 1.5-years post-operative
- Male or female
- Aged between 18-65 years
- Non-smoking
- Not lactose/milk/dairy intolerant
Exclusion
- Has not undergone an ileostomy and/or is less than 1.5 year post-operative
- Pregnant/ lactating females
- Smokers
- Lactose/milk/diary intolerant
Key Trial Info
Start Date :
April 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03765606
Start Date
April 9 2018
End Date
May 4 2018
Last Update
December 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Human Intervention Studies Unit, Ulster University
Coleraine, Co.Londonderry, United Kingdom, BT52 1SA